← Leaderboards
Hanjoon Ryu
$28,519,898
Attributed
$28,519,898
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $24.4M · FY2021–22$25M$18.8M$12.5M$6.3M$0
'21
'22
Funding mix
By agency
NIH$28,519,898 · 1
By mechanism
N02$28,519,898 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “2019-Ncov”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$193,846,216
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,671,433
- Theresa Engel · Leidos Biomedical Research, Inc.$36,854,858
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$23,410,676
- Yunda Huang · Fred Hutchinson Cancer Center$21,481,669
- Wally Narajowski$21,300,000
Research focus
2019-NcovAccelerationAcousticsAntibody TestAntigensAntigen TestBaseBiosensing TechniquesBiosensorCellular PhoneContractsCostCross ReactivityDesignDetectionDetection PlatformDevicesFluorescenceFrequenciesHuman DevelopmentImmunoglobulin GInfrastructureInvestigationLiquid Substance
Grant awards (2)
AWARD A CONTRACT FOR RADX TECH - QORVO TO SECURE AN EUA APPROVED POC ANTIGEN TEST SYSTEM AS WELL AS INCREASE AN INCREMENTAL DAILY CARTRIDGE PRODUCTION$4,158,139
N02 · FY2022 · HL · contact PI
AWARD A CONTRACT FOR RADX TECH - QORVO TO SECURE AN EUA APPROVED POC ANTIGEN TEST SYSTEM AS WELL AS INCREASE AN INCREMENTAL DAILY CARTRIDGE PRODUCTION$24,361,759
N02 · FY2021 · HL · contact PI